Vascular complications associated with transcatheter aortic valve replacement are an independent predictor of mortality, requiring early recognition and optimal percutaneous management.
This review highlights the critical importance of early recognition and optimal percutaneous management of vascular complications during TAVR, as they independently predict mortality.
Transcatheter aortic valve replacement (TAVR) is now an accepted pathway for aortic valve replacement for patients who are at prohibitive, severe and intermediate risk for traditional aortic valve surgery. However, with this rising uptrend and adaptation of this new technology, vascular complications and their management remain an Achilles heel for percutaneous aortic valve replacement. The vascular complications are an independent predictor of mortality for patients undergoing TAVR. Early recognition of these complications and appropriate management is paramount. In this article, we review the most commonly encountered vascular complications associated with currently approved TAVR devices and their optimal percutaneous management techniques.
Sardar et al. (2017) conducted a review in Aortic valve disease requiring TAVR. Transcatheter aortic valve replacement (TAVR) was evaluated. Vascular complications associated with transcatheter aortic valve replacement are an independent predictor of mortality, requiring early recognition and optimal percutaneous management.